Total serum tryptase: A predictive marker for KIT mutation in acute myeloid leukemia

Leukemia Research

Volumn 33, Issue 9, 2009, Pages 1282-1284

  Cairoli, Roberto ^a   Ripamonti, Carla Barbara ^a   Beghini, Alessandro ^b   Granata, Simonetta ^a   Grillo, Giovanni ^a   Brioschi, Matteo ^b   Nadali, Gianpaolo ^c   Viola, Assunta ^d   Cattaneo, Chiara ^e   Inropido, Liliana ^a   Ravelli, Erika ^a   Bertani, Giambattista ^a   Pezzetti, Laura ^a   Nichelatti, Michele ^a   Marocchi, Alessandro ^a   Rossi, Giuseppe ^e   Pizzolo, Giovanni ^c   Ferrara, Felicetto ^d   Nosari, Anna Maria ^a   Morra, Enrica ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d CARDARELLI HOSPITAL   (Italy)

^e UNIVERSITY OF BRESCIA   (Italy)

Author keywords

AML; KIT; Serum tryptase

Indexed keywords

STEM CELL FACTOR; TRYPTASE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; GENE MUTATION; GENETIC MARKER; GENETIC SCREENING; HUMAN; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CULTURE MEDIA, SERUM-FREE; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS C-KIT; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 67549142107     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.03.043     Document Type: Article

References (7)

1. Sperr W.R., Jordan J.H., Baghestanian M., et al. Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. Blood 98 (2001) 2200-2209
2. Klion A.D., Noel P., Akin C., et al. Elevated serum tryptase levels identify a subset of patients with myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood 101 (2003) 4660-4666
3. Beghini A., Ripamonti C.B., Castorina P., et al. Trisomy 4 leading to duplication of a mutated KIT allele in acute myeloid leukemia with mast cell involvement. Cancer Genet Cytogenet 119 (2000) 26-31
4. Sperr W., Drach J., Hauswirth A.W., et al. Myelomastocytic leukemia: evidence for the origin of mast cells from the leukemic clone and eradication by allogenic stem cell transplantation. Clin Cancer Res 11 (2005) 6787-6792
5. Cairoli R., Beghini A., Grillo G., et al. Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study. Blood 107 (2006) 3463-3468
6. Paschka P., Marcucci G., Ruppert A.S., et al. Adverse prognostic significance of KIT mutations in adult Acute Myeloid Leukemia with inv(16) and t(8;21): a Cancer and Leukaemia Group B study. J Clin Oncol 24 (2006) 3904-3911
7. Sperr W.R., Mitterbauer M., Mitterbauer G., et al. Quantitation of minimal residual disease in acute myeloid leukemia by tryptase monitoring identifies a group of patients with a high risk of relapse. Clin Cancer Res 11 (2005) 6536-6543